Lister J - Search Results

1

Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia.

Sadashiv SK, Hilton C, Khan C, Rossetti JM, Benjamin HL, Fazal S, Sahovic E, Shadduck RK, Lister J. Sadashiv SK, et al. Among authors: lister j. Cancer Med. 2014 Dec;3(6):1570-8. doi: 10.1002/cam4.321. Epub 2014 Aug 16. Cancer Med. 2014. PMID: 25132519 Free PMC article. Clinical Trial.

2

Treatment of acute myelogenous leukemia with outpatient azacitidine.

Sudan N, Rossetti JM, Shadduck RK, Latsko J, Lech JA, Kaplan RB, Kennedy M, Gryn JF, Faroun Y, Lister J. Sudan N, et al. Among authors: lister j. Cancer. 2006 Oct 15;107(8):1839-43. doi: 10.1002/cncr.22204. Cancer. 2006. PMID: 16967444 Free article.

3

Activity of azacitidine in chronic myelomonocytic leukemia.

Costa R, Abdulhaq H, Haq B, Shadduck RK, Latsko J, Zenati M, Atem FD, Rossetti JM, Sahovic EA, Lister J. Costa R, et al. Among authors: lister j. Cancer. 2011 Jun 15;117(12):2690-6. doi: 10.1002/cncr.25759. Epub 2010 Dec 23. Cancer. 2011. PMID: 21656746 Free article.

4

Azacitidine in the management of patients with myelodysplastic syndromes.

Khan C, Pathe N, Fazal S, Lister J, Rossetti JM. Khan C, et al. Among authors: lister j. Ther Adv Hematol. 2012 Dec;3(6):355-73. doi: 10.1177/2040620712464882. Ther Adv Hematol. 2012. PMID: 23606938 Free PMC article.

5

Rituximab-induced acute severe thrombocytopenia: a case series in patients with mantle cell lymphoma.

Sadashiv SK, Rao R, Fazal S, Lister J. Sadashiv SK, et al. Among authors: lister j. Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):602-5. doi: 10.1016/j.clml.2013.04.013. Epub 2013 Jul 17. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23870855 No abstract available.

6

Leptomeningeal Relapse of Acute Promyelocytic Leukemia.

Hadid T, Fazal S, Lister J. Hadid T, et al. Among authors: lister j. World J Oncol. 2014 Apr;5(2):77-80. doi: 10.14740/wjon761w. Epub 2014 May 6. World J Oncol. 2014. PMID: 29147382 Free PMC article.

7

Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era.

Beygi S, Sadashiv S, Reilly JB, Khan C, Lister J. Beygi S, et al. Among authors: lister j. Leuk Lymphoma. 2018 Dec;59(12):2847-2861. doi: 10.1080/10428194.2018.1443332. Epub 2018 Apr 4. Leuk Lymphoma. 2018. PMID: 29616868

8

Treatment of myelodysplastic syndromes with 5-azacytidine.

Gryn J, Zeigler ZR, Shadduck RK, Lister J, Raymond JM, Sbeitan I, Srodes C, Meisner D, Evans C. Gryn J, et al. Among authors: lister j. Leuk Res. 2002 Oct;26(10):893-7. doi: 10.1016/s0145-2126(02)00028-0. Leuk Res. 2002. PMID: 12163049

9

Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation.

Bartynski WS, Zeigler ZR, Shadduck RK, Lister J. Bartynski WS, et al. Among authors: lister j. AJNR Am J Neuroradiol. 2004 Feb;25(2):261-9. AJNR Am J Neuroradiol. 2004. PMID: 14970028 Free PMC article.

10

Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.

Lister J, Gryn JF, McQueen KL, Harris DT, Rossetti JM, Shadduck RK. Lister J, et al. Stem Cells Dev. 2007 Feb;16(1):177-86. doi: 10.1089/scd.2006.06500-HB. Stem Cells Dev. 2007. PMID: 17348813 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

775 results

Search Page

Filters